Complementing Lung Cancer: How Tumor Cells Co-opt the Host Complement System to Reach Bone
Author:
- 1 May 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 197 (9) , 1101-1103
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A review of human diseases caused or exacerbated by aberrant complement activationNeurobiology of Aging, 2017
- C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activationNature Communications, 2016
- C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial–mesenchymal transitionExperimental and Molecular Pathology, 2016
- Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell InfiltrationJournal of Biological Chemistry, 2015
- C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathwaysOncology Reports, 2015
- Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasivenessOncology Reports, 2014
- CXCL16 and CXCR6 Are Coexpressed in Human Lung Cancer In Vivo and Mediate the Invasion of Lung Cancer Cell Lines In VitroPLOS ONE, 2014
- CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cellsCancer Science, 2008
- Predictors of Survival in Patients With Bone Metastasis of Lung CancerClinical Orthopaedics and Related Research, 2008
- Pathology of Metastatic Tumors in BoneClinical Orthopaedics and Related Research, 1970